Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use
OptimalDosages

TB-500 / BPC-157 / KPV Blend Dosage & Reconstitution

TB-500 10 mg + BPC-157 10 mg + KPV 10 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

3.75 mg/mL · 3750 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — TB-500 / BPC-157 / KPV BlendYour Answer

—
24Draw To This Line
0.24That's This Many mL
33Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 24
30 mg ÷ 8 mL = 3.75 mg/mL  →  900 mcg ÷ 3.75 mg/mL = 0.24 mL  →  × 100 = 24 units—
Looks good. Draw to 24 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 33 doses.

2Week-By-Week Plan — TB-500 / BPC-157 / KPV Blend

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Low reported 600 mcg 1× daily (200 mcg each) 0.16 mL 16 u 50 doses
Standard 900 mcg 1× daily (300 mcg each) 0.24 mL 24 u 33 doses
Upper reported 1500 mcg 1× daily (500 mcg each) 0.4 mL 40 u 20 doses
Weeks until the top dose
4 weeks
Peptide used getting there
21 mg
Vials you'll need
1 × 30 mg
Once you're at the top dose
42 mg / 4 wk · 1.4 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — TB-500 / BPC-157 / KPV Blend

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 600 mcg daily 0.16 mL 16 u 14 8.4 mg
Weeks 3–4 900 mcg daily 0.24 mL 24 u 14 12.6 mg
Week 5 onward
per 4 weeks from here on		 1500 mcg daily 0.4 mL 40 u 28 42 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About TB-500 / BPC-157 / KPV BlendAbout This Peptide

Multi-Compound Blends
Also known as
TB-500 10 mg + BPC-157 10 mg + KPV 10 mg
Class
Multi-Compound Blends
Route
Subcutaneous
Half-life
Mixed
Evidence tier
Preclinical

An equal-thirds repair and anti-inflammatory combination — 10 mg of each component in a 30 mg vial. Because the three are pooled at a fixed 1:1:1 ratio you cannot move one without moving the others, so every dose delivers exactly one third of the total to each. A 900 mcg dose is 300 mcg apiece.

Buy TB-500 / BPC-157 / KPV Blendthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
See component entries: TB-500, BPC-157, KPV No blend-specific literature exists
No study has tested this combination as such. The ranges above are the ones where all three components sit inside their own reported figures at the same time.
Find on PubMed ↗

Newest Studies — —

—
Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

CJC-1295 / Ipamorelin Blend

A GHRH analogue paired with a selective ghrelin receptor agonist — the pairing rationale is that the two receptors act synergistic…

Tesamorelin / Ipamorelin Blend

Pairs a GHRH analogue with a selective GHRP in a 17 mg vial — roughly 65% tesamorelin, 35% ipamorelin. Worth knowing before you do…

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.